The development and use of novel, highly selective LPAR ligands and targeted gene knockout animal models have also allowed to identify LPAR2 as a central regulator of protection against γ-irradiation-induced intestinal injury [24, 25], NSAID-induced gastropathy [28] and toxin-induced diarrheas [62]. Here, LPAR2 is linked to stomach disorder.